Wu Chaodong, Khan Salmaan A, Peng Li-Jen, Li Honggui, Carmella Steven G, Lange Alex J
Dept. of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E536-43. doi: 10.1152/ajpendo.00126.2006. Epub 2006 Apr 18.
Hepatic insulin resistance is one of the characteristics of type 2 diabetes and contributes to the development of hyperglycemia. How changes in hepatic glucose flux lead to insulin resistance is not clearly defined. We determined the effects of decreasing the levels of hepatic fructose 2,6-bisphosphate (F26P(2)), a key regulator of glucose metabolism, on hepatic glucose flux in the normal 129J mice. Upon adenoviral overexpression of a kinase activity-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, the enzyme that determines F26P(2) level, hepatic F26P(2) levels were decreased twofold compared with those of control virus-treated mice in basal state. In addition, under hyperinsulinemic conditions, hepatic F26P(2) levels were much lower than those of the control. The decrease in F26P(2) leads to the elevation of basal and insulin-suppressed hepatic glucose production. Also, the efficiency of insulin to suppress hepatic glucose production was decreased (63.3 vs. 95.5% suppression of the control). At the molecular level, a decrease in insulin-stimulated Akt phosphorylation was consistent with hepatic insulin resistance. In the low hepatic F26P(2) states, increases in both gluconeogenesis and glycogenolysis in the liver are responsible for elevations of hepatic glucose production and thereby contribute to the development of hyperglycemia. Additionally, the increased hepatic gluconeogenesis was associated with the elevated mRNA levels of peroxisome proliferator-activated receptor-gamma coactivator-1alpha and phosphoenolpyruvate carboxykinase. This study provides the first in vivo demonstration showing that decreasing hepatic F26P(2) levels leads to increased gluconeogenesis in the liver. Taken together, the present study demonstrates that perturbation of glucose flux in the liver plays a predominant role in the development of a diabetic phenotype, as characterized by hepatic insulin resistance.
肝胰岛素抵抗是2型糖尿病的特征之一,且会导致高血糖的发展。肝脏葡萄糖通量的变化如何导致胰岛素抵抗尚不清楚。我们确定了降低葡萄糖代谢的关键调节因子——肝果糖2,6 -二磷酸(F26P₂)水平对正常129J小鼠肝脏葡萄糖通量的影响。通过腺病毒过表达激酶活性缺陷型的6 -磷酸果糖-2 -激酶/果糖-2,6 -二磷酸酶(该酶决定F26P₂水平),与基础状态下接受对照病毒处理的小鼠相比,肝脏F26P₂水平降低了两倍。此外,在高胰岛素血症条件下,肝脏F26P₂水平远低于对照组。F26P₂水平降低导致基础和胰岛素抑制的肝脏葡萄糖生成增加。而且,胰岛素抑制肝脏葡萄糖生成的效率降低(对照的抑制率为95.5%,而此处为63.3%)。在分子水平上,胰岛素刺激的Akt磷酸化减少与肝胰岛素抵抗一致。在肝脏F26P₂水平较低的状态下,肝脏中糖异生和糖原分解的增加导致肝脏葡萄糖生成增加,从而促进高血糖的发展。此外,肝脏糖异生增加与过氧化物酶体增殖物激活受体γ共激活因子-1α和磷酸烯醇式丙酮酸羧激酶的mRNA水平升高有关。本研究首次在体内证明,降低肝脏F26P₂水平会导致肝脏糖异生增加。综上所述,本研究表明肝脏葡萄糖通量的紊乱在以肝胰岛素抵抗为特征的糖尿病表型的发展中起主要作用。